Tilray Shares Up 21% On Deal With Grow Pharma To Deliver Cannabis Products In UKPosted by On


Tilray, Inc. (TLRY) shares are rising on Tuesday morning trade as the cannabis research and production pioneer announced an agreement with Grow Pharma to import and distribute Tilray’s medical cannabis products in the U.K.

Tilray said it expects to have a range of GMP-certified, medical cannabis products available for patients through prescriptions from private practice or the National Health Service in the UK by March 2021.

Currently, Tilray shares are at $36.58, up 21.55 percent from the previous close of $30.09. The shares have traded in a range of $2.43-$38.44 on average volume of 29,415,680.

For comments and feedback contact: editorial@rttnews.com

Business News



Original Author Link click here to read complete story..

Tilray, Inc. (TLRY) shares are rising on Tuesday morning trade as the cannabis research and production pioneer announced an agreement with Grow Pharma to import and distribute Tilray’s medical cannabis products in the U.K.

Tilray said it expects to have a range of GMP-certified, medical cannabis products available for patients through prescriptions from private practice or the National Health Service in the UK by March 2021.

Currently, Tilray shares are at $36.58, up 21.55 percent from the previous close of $30.09. The shares have traded in a range of $2.43-$38.44 on average volume of 29,415,680.

For comments and feedback contact: editorial@rttnews.com

Business News





Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.